Atrial fibrillation and heart failure with preserved ejection fraction are two of the most common heart conditions affecting older adults — and they have a habit of showing up together. When they do, each one tends to make the other worse, creating a cycle that can be challenging to manage. Understanding how the two are connected, and the approaches doctors use to treat them, can help patients and caregivers feel more informed and confident in conversations with their care team.
This article offers a clear, general overview. It is not medical advice, and every treatment decision should be made with a qualified healthcare provider who knows your individual situation.
What Are AFib and HFpEF?
Atrial fibrillation (AFib) is the most common sustained irregular heart rhythm. Instead of beating in a steady, coordinated way, the upper chambers of the heart (the atria) quiver rapidly and chaotically. This can cause palpitations, fatigue, shortness of breath, and — importantly — a raised risk of stroke.
Heart failure with preserved ejection fraction (HFpEF) is a form of heart failure in which the heart pumps out a normal percentage of blood with each beat, but the heart muscle has become stiff and doesn’t relax and fill properly. The result is similar to other forms of heart failure: breathlessness, fatigue, and fluid buildup, especially during exertion. HFpEF now makes up roughly half of all heart failure cases and is becoming more common as populations age.
Why AFib and HFpEF So Often Occur Together
These two conditions coexist in a large share of patients — studies suggest somewhere between 40% and two-thirds of people with HFpEF also have AFib. That overlap isn’t a coincidence.
A stiff, poorly relaxing heart raises pressure in the atria, stretching and remodeling them over time. That remodeling creates the perfect environment for AFib to start and persist. In turn, the irregular, often rapid rhythm of AFib reduces the heart’s efficiency and raises pressures further — which worsens heart failure symptoms. Each condition feeds the other, which is why doctors often describe it as a vicious cycle.
Why It Matters
The combination is more than the sum of its parts. People who have both AFib and HFpEF tend to face higher rates of hospitalization, more rapid progression of heart failure, a greater risk of stroke, and reduced quality of life compared with those who have either condition alone. That’s exactly why a thoughtful, coordinated management plan is so important — and why these patients often benefit most from comprehensive care.
An Integrated Approach to Management
Modern cardiology increasingly treats AFib in HFpEF not as two separate problems, but as one interconnected condition requiring a coordinated plan. A widely referenced framework is the holistic “ABC” approach to atrial fibrillation care, which broadly covers three pillars: avoiding stroke through appropriate clot prevention, better symptom control through rate or rhythm management, and addressing the cardiovascular and lifestyle factors that drive the disease. Below are the key pieces clinicians weigh.
Treating the Heart Failure Itself
One of the most significant recent advances has been the use of a class of medications called SGLT2 inhibitors. Originally developed for diabetes, these drugs have shown consistent benefit in HFpEF — reducing heart failure hospitalizations, improving symptoms and exercise capacity, and showing potential to reduce the burden of AFib as well. Managing the underlying heart failure well can sometimes ease the arrhythmia, which is why optimizing heart failure therapy is often a first priority. Specific medications and their suitability are always determined by a physician.
Rate Control vs. Rhythm Control
A central question in AFib management is whether to focus on rate control (allowing the irregular rhythm to continue but keeping the heart rate in a safe range with medication) or rhythm control (trying to restore and maintain a normal rhythm). The best choice depends on the individual — their symptoms, how long they’ve had AFib, and their overall heart health. There’s growing evidence that restoring normal rhythm may be especially valuable for certain HFpEF patients, particularly those with earlier-stage AFib.
Catheter Ablation
For some patients, a procedure called catheter ablation — which targets the heart tissue responsible for the abnormal signals — is considered as part of a rhythm-control strategy. Research suggests an ablation-based approach may improve outcomes for selected patients, especially those with paroxysmal (intermittent) or early persistent AFib. Whether ablation is appropriate is a highly individual decision made with an electrophysiologist or cardiologist.
Stroke Prevention
Because AFib substantially raises stroke risk, assessing that risk and, when appropriate, using blood-thinning (anticoagulant) therapy is a cornerstone of management. Doctors use established risk scores to weigh the benefit of clot prevention against bleeding risk for each person. This is one of the most important — and most individualized — parts of the whole plan.
Managing Comorbidities and Risk Factors
Both AFib and HFpEF are strongly tied to conditions like high blood pressure, obesity, diabetes, sleep apnea, and kidney disease. Aggressively managing these — along with lifestyle factors such as physical activity, weight, and alcohol intake — can meaningfully reduce the burden of both conditions. In many cases, addressing these root contributors is just as important as the heart-specific treatments.
Working With Your Care Team
Because AFib in HFpEF is complex and highly individual, care is best delivered by a coordinated team that may include a primary care physician, a cardiologist, and sometimes an electrophysiologist or heart failure specialist. The right plan looks different for every patient, and it often evolves over time as the condition and the person’s needs change.
If you or a loved one is navigating both conditions, the most valuable step is an open, ongoing conversation with your healthcare providers — bringing your questions, your symptoms, and your goals to every visit.
The Bottom Line
AFib and HFpEF frequently travel together, each amplifying the other, and the combination carries real risks. But cardiology has made meaningful progress in understanding and managing it — from newer heart failure medications to refined rhythm-control strategies and a more holistic, coordinated approach to care. With the right plan, tailored by a knowledgeable medical team, many people manage both conditions and maintain a good quality of life.